Your browser doesn't support javascript.
loading
Diabetes, Atherosclerosis, and Stenosis by AI.
Jonas, Rebecca A; Crabtree, Tami R; Jennings, Robert S; Marques, Hugo; Katz, Richard J; Chang, Hyuk-Jae; Stuijfzand, Wijnand J; van Rosendael, Alexander R; Choi, Jung Hyun; Doh, Joon-Hyung; Her, Ae-Young; Koo, Bon-Kwon; Nam, Chang-Wook; Park, Hyung-Bok; Shin, Sang-Hoon; Cole, Jason; Gimelli, Alessia; Khan, Muhammad Akram; Lu, Bin; Gao, Yang; Nabi, Faisal; Nakazato, Ryo; Schoepf, U Joseph; Driessen, Roel S; Bom, Michiel J; Thompson, Randall C; Jang, James J; Ridner, Michael; Rowan, Chris; Avelar, Erick; Généreux, Philippe; Knaapen, Paul; de Waard, Guus A; Pontone, Gianluca; Andreini, Daniele; Al-Mallah, Mouaz H; Guglielmo, Marco; Bax, Jeroen J; Earls, James P; Min, James K; Choi, Andrew D; Villines, Todd C.
Afiliación
  • Jonas RA; Department of Internal Medicine, Thomas Jefferson University Medical Center; Philadelphia, PA.
  • Crabtree TR; Cleerly, Inc., New York, NY.
  • Jennings RS; Cleerly, Inc., New York, NY.
  • Marques H; Faculdade de Medicina da Universidade Católica Portuguesa, Lisboa, Portugal.
  • Katz RJ; The George Washington University School of Medicine & Health Sciences, Washington, DC.
  • Chang HJ; Division of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
  • Stuijfzand WJ; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
  • van Rosendael AR; Department of Cardiology, Leiden University Medical Center, Amsterdam, the Netherlands.
  • Choi JH; Ontact Health, Inc., Seoul, South Korea.
  • Doh JH; Division of Cardiology, Inje University Ilsan Paik Hospital, Goyang, South Korea.
  • Her AY; Kang Won National University Hospital, Chuncheon, South Korea.
  • Koo BK; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Nam CW; Cardiovascular Center, Keimyung University Dongsan Hospital, Daegu, South Korea.
  • Park HB; Division of Cardiology, Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, South Korea.
  • Shin SH; Division of Cardiology, Department of Internal Medicine, Ewha Women's University Seoul Hospital, Seoul, South Korea.
  • Cole J; Mobile Cardiology Associates, Mobile, AL.
  • Gimelli A; Department of Imaging, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
  • Khan MA; Cardiac Center of Texas, McKinney, TX.
  • Lu B; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing, China.
  • Gao Y; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing, China.
  • Nabi F; Houston Methodist Hospital, Houston, TX.
  • Nakazato R; Cardiovascular Center, St. Luke's International Hospital, Tokyo, Japan.
  • Schoepf UJ; Medical University of South Carolina, Charleston, SC.
  • Driessen RS; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
  • Bom MJ; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
  • Thompson RC; St. Luke's Mid America Heart Institute, Kansas City, MO.
  • Jang JJ; Kaiser Permanente San Jose Medical Center, San Jose, CA.
  • Ridner M; Heart Center Research, LLC, Huntsville, AL.
  • Rowan C; Renown Heart and Vascular Institute, Reno, NV.
  • Avelar E; Oconee Heart and Vascular Center at St Mary's Hospital, Athens, GA.
  • Généreux P; Gagnon Cardiovascular Institute at Morristown Medical Center, Morristown, NJ.
  • Knaapen P; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
  • de Waard GA; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
  • Pontone G; Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Andreini D; Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Al-Mallah MH; Houston Methodist Hospital, Houston, TX.
  • Guglielmo M; Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
  • Bax JJ; Department of Cardiology, Leiden University Medical Center, Amsterdam, the Netherlands.
  • Earls JP; Cleerly, Inc., New York, NY.
  • Min JK; Cleerly, Inc., New York, NY.
  • Choi AD; The George Washington University School of Medicine & Health Sciences, Washington, DC.
  • Villines TC; Division of Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA.
Diabetes Care ; 46(2): 416-424, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36577120
OBJECTIVE: This study evaluates the relationship between atherosclerotic plaque characteristics (APCs) and angiographic stenosis severity in patients with and without diabetes. Whether APCs differ based on lesion severity and diabetes status is unknown. RESEARCH DESIGN AND METHODS: We retrospectively evaluated 303 subjects from the Computed TomogRaphic Evaluation of Atherosclerotic Determinants of Myocardial IsChEmia (CREDENCE) trial referred for invasive coronary angiography with coronary computed tomographic angiography (CCTA) and classified lesions as obstructive (≥50% stenosed) or nonobstructive using blinded core laboratory analysis of quantitative coronary angiography. CCTA quantified APCs, including plaque volume (PV), calcified plaque (CP), noncalcified plaque (NCP), low-density NCP (LD-NCP), lesion length, positive remodeling (PR), high-risk plaque (HRP), and percentage of atheroma volume (PAV; PV normalized for vessel volume). The relationship between APCs, stenosis severity, and diabetes status was assessed. RESULTS: Among the 303 patients, 95 (31.4%) had diabetes. There were 117 lesions in the cohort with diabetes, 58.1% of which were obstructive. Patients with diabetes had greater plaque burden (P = 0.004). Patients with diabetes and nonobstructive disease had greater PV (P = 0.02), PAV (P = 0.02), NCP (P = 0.03), PAV NCP (P = 0.02), diseased vessels (P = 0.03), and maximum stenosis (P = 0.02) than patients without diabetes with nonobstructive disease. APCs were similar between patients with diabetes with nonobstructive disease and patients without diabetes with obstructive disease. Diabetes status did not affect HRP or PR. Patients with diabetes had similar APCs in obstructive and nonobstructive lesions. CONCLUSIONS: Patients with diabetes and nonobstructive stenosis had an association to similar APCs as patients without diabetes who had obstructive stenosis. Among patients with nonobstructive disease, patients with diabetes had more total PV and NCP.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Estenosis Coronaria / Diabetes Mellitus / Aterosclerosis / Placa Aterosclerótica Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Care Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Estenosis Coronaria / Diabetes Mellitus / Aterosclerosis / Placa Aterosclerótica Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Care Año: 2023 Tipo del documento: Article